IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 198 filers reported holding IMPAX LABORATORIES INC in Q4 2016. The put-call ratio across all filers is 269.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,350,000 | -16.8% | 165,000 | -34.0% | 1.14% | -22.6% |
| Q2 2017 | $4,025,000 | +89.3% | 250,000 | +48.8% | 1.47% | +48.8% |
| Q1 2017 | $2,126,000 | +52.8% | 168,030 | +60.0% | 0.99% | +49.1% |
| Q4 2016 | $1,391,000 | -54.9% | 105,000 | -19.2% | 0.66% | -57.2% |
| Q3 2016 | $3,081,000 | +52.1% | 130,000 | +174.4% | 1.55% | +61.4% |
| Q4 2015 | $2,025,000 | +15.0% | 47,369 | -5.3% | 0.96% | +12.6% |
| Q3 2015 | $1,761,000 | -31.1% | 50,000 | -10.2% | 0.85% | -3.7% |
| Q2 2015 | $2,556,000 | +36.3% | 55,669 | +39.2% | 0.89% | +39.0% |
| Q1 2015 | $1,875,000 | +19.4% | 40,000 | -19.4% | 0.64% | +0.3% |
| Q4 2014 | $1,571,000 | +4.7% | 49,600 | -0.8% | 0.64% | -16.0% |
| Q2 2014 | $1,500,000 | – | 50,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 423,161 | $13,406,000 | 7.47% |
| Aravt Global | 2,300,000 | $72,864,000 | 5.43% |
| Slate Path Capital LP | 2,330,000 | $73,814,000 | 5.16% |
| Orbimed Advisors | 6,678,000 | $211,559,000 | 2.02% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Iguana Healthcare Management, LLC | 100,000 | $3,168,000 | 1.53% |
| Penn Capital Management Company, LLC | 709,045 | $22,463,000 | 0.94% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 250,000 | $7,920,000 | 0.79% |
| NEW AMSTERDAM PARTNERS LLC/NY | 276,169 | $8,749,000 | 0.76% |
| Matarin Capital Management, LLC | 52,932 | $1,676,886,000 | 0.74% |